Immunotherapy FDA Approved

CAR-T Cell Therapy Treatment

An advanced form of adoptive cellular immunotherapy that harnesses and enhances the patient’s own immune system to recognize and eliminate malignant cells with high specificity.

CAR-T Cell Therapy Treatment

90%


Response In Leukemia

FDA


Approved Therapy

1


Single Infusion

Overview

In this personalized treatment approach, autologous T lymphocytes are collected from the patient through leukapheresis and genetically engineered ex vivo to express a chimeric antigen receptor (CAR).

This synthetic receptor enables T cells to directly identify tumor-associated antigens on cancer cells, independent of major histocompatibility complex (MHC) presentation. Once modified, the CAR-T cells are expanded in a controlled laboratory environment and subsequently infused back into the patient.

Mechanism of Action

CAR-T cells combine three critical components to effectuate their kill mechanism:
01

Antigen-Binding Domain

Typically derived from a monoclonal antibody, this extracellular domain allows the T-cell to lock onto specific cancer cell markers.

02

Transmembrane Domain

This structural component anchors the receptor to the T-cell surface, ensuring stability during the attack phase.

03

Intracellular Signaling

Domains such as CD3ζ and costimulatory molecules like CD28 or 4-1BB activate the T-cell to proliferate and destroy the target.

Advantages

null
icon

Highly Targeted

Specifically engineered to target cancer cells while sparing most healthy tissues.

icon

Durable Remissions

The ability to induce long-lasting remission even in advanced stages.

icon

Immune Surveillance

Modified cells can persist in the body, providing ongoing protection against recurrence.

icon

Reference Efficacy

Effective in treatment-resistant or relapsed cancers where other lines have failed.

Clinical Applications

CAR-T Cell Therapy has demonstrated remarkable clinical efficacy, particularly in hematologic malignancies:
icon

Acute Lymphoblastic Leukemia (ALL)

High success rates in treating children and young adults.

icon

Diffuse Large B-cell Lymphoma

A leading treatment for this aggressive type of non-Hodgkin lymphoma.

Cell Hands Effect Effect

SEARCH IN
frequently asked question

(Car-T Cell)

(TIL Therapy)

  • What is TIL therapy?

    TIL (Tumor-Infiltrating Lymphocyte) therapy is an immunotherapy approach in which a patient’s own immune cells are harvested, expanded in the laboratory, and reinfused to fight cancer.

  • Is TIL therapy suitable for all types of cancer?

    No. TIL therapy is currently used more commonly in certain solid tumors, especially metastatic melanoma. Patient suitability is determined on an individual basis.

  • What are the main advantages of TIL therapy?

    Its personalized nature and its ability to strengthen the immune system in a targeted way are considered its main advantages.